BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6428991)

  • 1. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
    Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C
    Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow involvement and leukemia in advanced non-Hodgkin's lymphomas. Analysis of 58 cases.
    Song SZ; Wang QL; Wang YP
    Chin Med J (Engl); 1982 Sep; 95(9):635-40. PubMed ID: 6817986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of malignant non-Hodgkin's-lymphomas with reference to Kiel classification: centrocytic lymphoma, centroblastic-centrocytic lymphoma, lymphoblastic lymphoma, immunoblastic lymphoma].
    Brittinger G; Bartels H; Bremer K; Dühmke E; Gunzer U; König E; Stein H
    Hamatol Bluttransfus; 1976; 18():211-23. PubMed ID: 786810
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological profile in patients with non-Hodgkin's lymphomas.
    Urasiński I; Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):467-74. PubMed ID: 6689470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leukemic conversion of non-Hodgkin's lymphoma].
    Itoyama S; Mohri N; Mori S
    Nihon Rinsho; 1983 Nov; 41(11):2506-10. PubMed ID: 6584656
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognosis of non-Hodgkin's lymphoma. 1. T- and B-lymphomas and their primary sites].
    Shimoyama M; Minato K; Seki S; Nagai M; Takenaka T; Kitahara T; Konda C; Tobinai K; Watanabe S
    Rinsho Ketsueki; 1985 Jun; 26(6):906-15. PubMed ID: 3877823
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
    Kamthan M; Joshi N; Sharma ML
    Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Marrow infiltration in malignant non-Hodgkin's lymphoma (71 consecutive bone marrow biopsies)].
    Bettini R; Lenotti MA; Frigerio B
    Haematologica; 1982 Aug; 67(4):567-75. PubMed ID: 6815015
    [No Abstract]   [Full Text] [Related]  

  • 11. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the blast cell in childhood non-Hodgkin's lymphoproliferative malignancies.
    Coccia PF
    Semin Oncol; 1977 Sep; 4(3):287-96. PubMed ID: 335518
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histopathology of leukaemic non-Hodgkin's lymphoma in bone marrow].
    Buhr T; Länger F; Schlué J; V Wasielewski R; Kreipe H
    Pathologe; 2002 Nov; 23(6):438-47. PubMed ID: 12436297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphomas. analysis of 109 Japanese cases with the use of LSGJ classification.
    Shimizu M; Miura M; Kitahara M; Katayama I
    Am J Pathol; 1982 Jan; 106(1):30-9. PubMed ID: 7034544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood non-Hodgkin's lymphoma.
    Buchanan GR
    Tex Med; 1985 Mar; 81(3):46-9. PubMed ID: 3885466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies of leukemic non-Hodgkin's lymphoma. II. Clinicopathological aspects and prognostic factors].
    Takenaka T; Kimura K; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K
    Nihon Ketsueki Gakkai Zasshi; 1983 Nov; 46(6):1256-65. PubMed ID: 6369857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies of leukemic non-Hodgkin's lymphoma. III. Weight of leukemic conversion and prognostic factors].
    Takenaka T; Kimura K; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K
    Nihon Ketsueki Gakkai Zasshi; 1983 Nov; 46(6):1266-71. PubMed ID: 6369858
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
    Tsartsidze E; Betaneli M
    Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathological features of T- and B-cell lymphomas. The old terms corresponding with those of the new classification (LSG classification) for non-Hodgkin's lymphoma (author's transl)].
    Tajama K; Suchi T
    Rinsho Byori; 1980 Aug; 28(8):724-32. PubMed ID: 6970829
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and hematological observations of the bone marrow involvement and leukemia in advanced cases of non-Hodgkin's lymphomas: an analysis of 58 cases].
    Song SZ
    Zhonghua Nei Ke Za Zhi; 1982 Sep; 21(9):520-2. PubMed ID: 7151562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.